CASE DISCUSSION
Newer Biochemical Bone Health Markers
Presented by Dr. Sangeeta KapoorViews
223
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
This session will explore the role of newer biochemical markers in assessing bone health and skeletal metabolism. It will cover emerging biomarkers, their clinical significance, and how they can complement conventional investigations in the evaluation of osteoporosis and metabolic bone disorders....
Case Summary
- Bone remodeling is a continuous, tightly regulated process involving the coordinated activity of osteoblasts and osteoclasts, governed by the Wnt-beta-catenin and RANK-RANKL-OPG signaling pathways. While traditional markers like total serum alkaline phosphatase and urinary hydroxyproline are widely available, they often lack specificity due to their expression in multiple tissues. Clinical practice is shifting toward more robust, bone-specific markers that better reflect real-time bone turnover.
Speaker Profile
Dr. Sangeeta Kapoor
Professor & Head, VIMS Hospital, Uttar PradeshDr. Sangeeta Kapoor is a distinguished academician and clinician serving as Professor & Head at VIMS Hospital, Uttar Pradesh. With extensive experience in patient care, teaching, and clinical leadership, she has contributed significantly to advancing evidence-based medical practice and training future healthcare professionals. Dr. Kapoor is actively involved in academic initiatives and professional education, making her a respected voice in her field. Her expertise and commitment to quality healthcare continue to inspire clinicians and students alike.